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ABSTRACT 
A search was made for new degra- 
dative pathways for glucosyl and galac- 
tosyl ceramides in an effort to explain the 
failure of these lipids to accumulate in 
the brains of  children with Krabbe's or 
Gaucher's disease. Using various buffers 
and incubation conditions, we tested 
brain homogenates from 12 day olc] rats 
with the stearate-labeled and galactose- 
labeled lipids. No evidence for direct 
deacylation (and formation of psycho- 
sines) could be obtained, nor was there 
any evidence for transacylation of sphin- 
gosyl phosphoryl choline or oxidation of 
the 6 position of the galactose moiety. 
Two new derivatives of galactosyl cer- 
amide were observed, possibly fatty acid 
esters of unknown polar compounds. It is 
tentatively proposed that the etiology of 
infantile Krabbe's and Gaucher's dis- 
eases involves, not an accumulation of 
galactosyl and glucosyl ceramides, with 
consequent formation of toxic products, 
but rather malfunction of some other role 
of the corresponding glycosidases. 
I N T R O D U C T I O N  
The only known pathway for catabolism of 
glucosyl and galactosyl ceramides is through 
two fl-glycosidases (l ,2).  In the case of the 
galactosidase, the enzyme appears to be quite 
specific and can be distinguished from a num- 
ber of other /3-galactosidases (1,3,4). It does 
seem to attack galactosyl sphingosine (5-7), a 
lipid which hypothetically could be derived 
from galactosyl ceramide via an amidase. Gluco- 
cerebrosidase probably is not  the only mam- 
malian fl-glucosidase, judging from comparisons 
between aryl glucoside and ceramide glucoside 
as substrates (2,8). 
In Krabbe's disease (infantile globoid leuko- 
dystrophy), the primary genetic lesion appears 
to be in the cerebroside galactosidase (9). The 
striking feature of this disease is that there is no 
accumulation of galactosyl ceramide in brain; 
but instead there is a marked, fatal lack of 
brain development. Miyatake and Suzuki (5) 
have made the suggestion that the galactosyl 
ceramide is converted to galactosyl sphingosine, 
which may be highly toxic and thus cause the 
fatal failure to develop. This alternative cata- 
bolic product is assumed to be so toxic that 
detectable concentrations fail to accumulate. 
The failure of cerebroside to accumulate does 
not seem to be due to loss of the synthetic 
enzymes which make the ceramides and galac- 
tosyl ceramides (10). 
A similar situation could be postulated in 
the infantile form of Gaucher's disease, which 
seems to be due to a severe lack of glucosidase 
(1 1). The young brain is an active manufacturer 
of glucosyl ceramide for use in making gangli- 
osides; and there seems to be an active catab- 
olism of gangliosides, so one should expect the 
brain to accumulate much glucosyl ceramide in 
infantile Gaucher's disease. Instead there seems 
to be no accumulation, and the brain simply 
fails to mature, degenerating to a fatal con- 
dition, as in the Krabbe disorder. (Although a 
few cases of the infantile form of the disease 
have been found to accumulate some glucocere- 
broside in the brain, the lipid appears to be in 
unusual cells, rather than in neurons [12]).  
Thus one might suggest that glucosyl ceramide 
could be converted to glucosyl sphingosine, a 
potentially highly toxic substance. 
While our early studies on galactosyl cer- 
amide breakdown (1) gave negative evidence for 
fatty acid release (except for a bit that could be 
attributed to ceramidase action), no such ex- 
amination appears to have been made in the 
case of glucosyl ceramide. Consequently we 
have reopened the question with the aid of 
cerebrosides labeled in the galactose and fatty 
acid moieties by incubating them with brain 
homogenates and exanfining the radioactive 
products. No evidence for fatty acid release 
could be obtained, but some conversion of 
galactosyl ceramide to two unknown polar 
substances was observed. 
M A T E R I A L S  A N D  METHODS 
Substrates 
The synthesis of  the two cerebrosides la- 
beled with [1-~4C]stearic acid has been de- 
scribed before (13,14). Examination of the 
galactosyl ceramide by thin layer chromatog- 
raphy (TLC) radioautography showed only one 
spot, and elution of this spot and other plate 
regions indicated a radiopurity of over 97%. 
The glucosyl ceramide showed a slight radioac- 
tive streak above and below the cerebroside 
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Per cent conversion of 
labeled substrate 
Emulsion On Celite 
Substrate Buffer (8 mg) (32 mg) (32 nag) 
Galactosyl ceramide Phosphate 7.0 0.03 a 0.03 a 0.04 a 
200,000 cpm Citrate 4.0 .03 .04 .04 
Citrate 5.0 .03 .04 .04 
Citrate 6.2 .03 .06 --- 
Phosphate 6.0 .04 .04 .05 
Phosphate 7.0 .04 .05 .04 
Phosphate 8.0 .04 .05 --- 
Tris 7.2 .04 .05 --- 
Tris 8.0 .06 .06 .05 
Tris 8.9 .05 .04 .05 
Glucosyl ceramide b Citrate 5.0 1.76 a 0.20 a 
200,000 cpm Citrate 4.0 1.39 .28 
Citrate 5.0 5.78 .28 
Phosphate 6.0 4.33 .50 
Phosphate 7.0 3.79 .35 
Tris 8.0 1.38 .34 
Tris 8.9 1.42 .34 
aData from boiled enzyme. These numbers were not subtracted from the others. 
bThe glucocerebroside used to make the emulsion had not been purified recently and 
yielded a high blank in the fatty acid fraction. 
wh ich  cou ld  be the  d ihyd rosph ingos ine  form.  
The  r ad iopur i ty ,  t ak ing  the  mino r  spot  to  be an  
impur i ty ,  was 96%. Galac tosyl  ce ramide  labe led  
in the  6 pos i t ion  o f  the  sugar w i t h  t r i t i um  was 
made  by  the  b o r o h y d r i d e  m e t h o d  (15) .  Sphin-  
gosyl p h o s p h o r y l  chol ine  h y d r o c h l o r i d e  was 
made  f rom s p h i n g o m y e l i n  by  hydro lys i s  in  
methanol -water -HC1 (16)  and  pur i f ied  wi th  a 
long  silica gel co lumn .  
The  cerebrosides  were t e s t ed  as emuls ions  in 
Tween  20, Myrj 59, and  Na t a u r o c h o l a t e  (17) ;  
tris oleate  was o m i t t e d  f r o m  the  emuls ion .  
Enzyme Test Procedure 
Some i n c u b a t i o n s  were p e r f o r m e d  wi th  0 .4  
ml cerebros ide  emuls ion  (0.1 mg cerebros ide) ,  
0.1 m m o l e  buf fer ,  0.2 ~zmoles d i t h io th re i t o l ,  
and  bra in  h o m o g e n a t e  in a t o t a l  vo lume  of  1 
mi. The  h o m o g e n a t e  was made  f r o m  bra ins  of  
12-day-old Sprague-Dawley rats  in 11 vo lumes  
cold  water.  The h o m o g e n a t e  was s to red  in 
po r t i ons  in the  freezer,  and  each  series was 
carr ied ou t  on  mater ia l  wh ich  had  been  t h a w e d  
only  once.  The  rats  were chosen  to  be at the  
p re -mye t ina t ion  age, w h i c h  co r r e sponds  more  
closely to the  h u m a n  disorders  and  w h i c h  
min imizes  d i lu t ion  o f  the  rad ioac t ive  subs t r a t e  
by  e n d o g e n o u s  cerebroside.  
Some i n c u b a t i o n s  were carr ied ou t  in  the  
absence  of  de te rgen t ,  and  the  cerebros ide  t h e n  
was coa ted  o n t o  50 mg  Celi te Ana ly t i ca l  F i l t e r  
Aid by  evapora t i on  f rom solu t ion .  To this  was 
added  0.1 m m o l e  buf fer ,  0 .2  p m o l e  d i th io th re -  
i tol ,  and  b ra in  h o m o g e n a t e ,  as above.  
Where  sphingosyl  p h o s p h o r y l  cho l ine  was 
added  to  the  mix ture ,  0 .2  mg l ip id  was appl ied  
to  the  b o t t o m  of  the  i n c u b a t i o n  tube  by  
evapora t ion  f rom so lu t i on  pr ior  to  the  o t h e r  
addi t ions .  The  l ip id  dissolved readi ly  in  each  
buffer .  
Buffers  used  were Na-ci t ra te ,  Na-phospha te ,  
and Tris-HCl at  pH n o t e d  in the  tables.  The  
tubes  were shaken  1 hr  at  37 C, t h e n  20 ml 
c h l o r o f o r m - m e t h a n o l  were added.  The  mix tu r e  
was ac id i f ied  wi th  4 ml 0.5 M ci tr ic  acid, and  
the  r e su l t an t  u p p e r  l ayer  was discarded.  The  
lower  layer  was washed  w i th  I0  ml m e t h a n o l -  
water  (1 :1 )  and  f i l te red  to  r emove  pro te in .  The  
f i l t ra te  was e v a p o r a t e d  to  dryness  u n d e r  vacu-  
u m  wi th  the  aid of  b e n z e n e  addi t ions ,  t a k e n  up  
in c h l o r o f o r m ,  and  appl ied  to  a silica gel 
c o l u m n  (0 .4  x 6 cm,  0 .32 g). A fa t ty  acid 
f r ac t ion  was e lu t ed  w i th  10 ml c h l o r o f o r m ,  a 
cerebros ide  f r ac t ion  w i t h  10 ml c h l o r o f o r m -  
m e t h a n o l  ( 9 0 : 1 0 ) ,  a n d  a polar  l ip id  f r ac t ion  
w i th  10 ml c h l o r o f o r m - m e t h a n o l  (1 :2 ) .  Por- 
t ions  of  the  f irst  and th i rd  f r ac t ions  were 
c o u n t e d  and  e x a m i n e d  by  TLC rad ioau tog-  
raphy.  
RESULTS 
E x a m i n a t i o n  of  t he  first  c o l u m n  f r ac t ion  
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T A B L E  II 
Fatty Acid Fraction Produced from Incubations with Brain Homogenate and 
Labeled Glucocerebroside in the Presence of Glucosidase Inhibitors 
Per cent conversion 
Buffer Inhibitor of cerebroside 
Citrate 5.0 a None 5.37 
None (boiled enzyme) 1.76 
5/~M hexyl glucosyl sphingosine 2.05 
5 mM 6-gluconolactone 1.94 
Phosphate 6.0 b None 0.33 
None (boiled enzyme) .26 
20 ~zM hexyl glucosyl sphingosine .17 
10 mM 6-gluconolactone .22 
aThese incubations run with cerebroside emulsion and 16 mg brain. 
bThese incubations run with cerebroside dispersed on celite and 32 mg brain. 
from galactocerebroside incubations showed 
very slight formation of  free fatty acid (Table 
I). While radioactive ceramide was formed in 
the incubations containing detergents and tau- 
rocholate, there was evidently insufficient cer- 
amide for further conversion at an appreciable 
speed into free fatty acid. In the case of 
glucocerebroside, the first column fraction did 
show an appreciable amount of radioactivity, 
especially at pH 5 with the emulsified substrate 
and pH 6 with the nonemulsified substrate. The 
formation of fatty acid was much less in the 
tubes lacking taurocholate and detergents, 
which can be explained by the well-established 
need for these adjuncts in the normal catabolic 
pathway (via g/ucosidase and ceramidase). Evi- 
dently glucosidase was sufficiently active in 
these preparations to raise the ceramide level to 
the point where ceramidase action could be 
observed. 
Further evidence for tiffs interpretation was 
obtained by incubating labeled glucocerebro- 
side in the presence of inhibitors of glucosidase 
(Table II). Both inhibitors used brought down 
the yield of  labeled fatty acid close to the blank 
level. 
Assuming the inhibitors also do not block 
the hypothetical amidase, we conclude that the 
radioactivity observed without inhibitors is due 
to a rapid hydrolysis of glucocerebroside to 
ceramide, and then to sphingosine and free 
fatty acid. 
The polar lipid fraction (Table III) showed 
some conversion of galactocerebroside to more 
polar material, particularly at pH 6 and 8 with 
emulsions or plain cerebroside. This conversion 
was greater in tubes containing more homog- 
enate and generally seemed higher in the 
absence of detergents. Radioautography of a 
TLC plate (silica gel, chloroform-methanol- 
water [117:45:8] )  showed that this fraction 
contained a radioactive band at the cerebroside 
position (Rf 0.61), evidently due to some 
trailing from the second column eluent, and 
two bands at Rf 0.52 and 0.38. When this 
examination was carried out with the  same 
column fraction after alkaline methanolysis at 
room temperature for 1 hr (18), the cerebroside 
band was found to be unchanged, but the two 
lower bands were now even lower, with Rf 0.29 
and 0.24. From this it would appear that the 
two metabolic products were fatty acid esters 
of some polar cerebroside derivative. The posi- 
tions of  the methanolyzed compounds did not 
correspond to any known galactosyl ceramide 
derivatives, including galactosyl galactosyl cer- 
am/de. The lower band corresponded to the 
faster region of cerebroside sulfate or lecithin. 
Some conversion of glucocerebroside to 
polar material also was observed in the absence 
of detergent (Table l i d  but was not charac- 
terized further, because we assumed that this 
was a series of ganglioside intermediates made 
from endogenous sugar donors. The glucosidase 
inhibitors had no effect on this conversion. 
Incubations also were carried out with stea- 
rate-labeled galactosyl ceramide and unlabeled 
sphingosyl phosphoryl choline (lysosphingomy- 
elin) on the theory that the cerebroside is not 
degraded by an amidase but by a specific fatty 
acyl transferase which could form galactosyl 
sphingosine and sphingomyelin. Here too there 
was some conversion to polar l ind ,  appearing in 
the third column eluent, but this was to the 
same extent as that found without the lyso- 
sphingomyelin. TLC radioautography showed 
the same labeled bands without any sign of 
radioactivity in the sphingomyelin. 
Another possible catabolic route for galacto- 
cerebroside was tested by incubations with 
stearoyl [6 -3H]galactosyl sphingosine, dis- 
persed on Celite or emulsified, as described 
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T A B L E  III 
Polar  L ip id  F r a c t i o n  P r o d u c e d  b y  I n c u b a t i o n s  w i t h  
Bra in  H o m o g e n a t e  a n d  S t e a r a t e - L a b e l e d  C e r e b r o s i d e s  
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S u b s t r a t e  
Per cen t  c o n v e r s i o n  o f  
l abe l ed  s u b s t r a t e  
E m u l s i o n  O n  Celi te 
Buf f e r  (8 mg)  (32  mg)  (32  mg)  
G a l a c t o s y l  c e r a m i d e  
G l u c o s y l  c e r a m i d e  b 
P h o s p h a t e  7 .0  0 . 2 4  a 0 . 3 6  a 0 . 8 4  a 
C i t r a t e  4 .0  .20  . 84  .65  
C i t r a t e  5 .0  .22 .58  .61 
C i t r a t e  6.2 .17  1 .10  - -  
P h o s p h a t e  6 .0  .32  1 .28 2 .15  
P h o s p h a t e  7 .0  .32  .97  1 .26  
P h o s p h a t e  8.0 . 33  . 86  - -  
Tris 7 .2  .31 .65  - -  
Tris 8.0 . 20  1 .62 1 .06  
Tris 8.9 . 24  .71 1.81 
C i t r a t e  5.0 2 . 7 6  a 1 .42 a 
C i t r a t e  4 .0  1 .89 1 .72 
Citrate 5.0 1 .48  1.71 
P h o s p h a t e  6 .0  1 .74  2 . 6 4  
P h o s p h a t e  7 .0  2 . 0 9  1 .94  
Tris 8 .0  2 .12  2 .41 
Tris 8.9 1 .95 1 .50  
P h o s p h a t e  6 .0  .68  a 
P h o s p h a t e  6 .0  1 .12  
P h o s p h a t e  6 .0  1 .28 c 
P h o s p h a t e  6 .0  1 .04  d 
a D a t a  f r o m  bo i l ed  e n z y m e .  
b T h e  g l u c o c e r e b r o s i d e  u sed  t o  m a k e  the  e m u l s i o n  h a d  n o t  b e e n  p u r i f i e d  r e c e n t l y  a n d  
y i e l d e d  a h igh  l~lank in t he  p o l a r  l ip id  f r a c t i o n .  
C I n c u b a t i o n  i n c l u d e d  2 0  ~tM h e x y l  g l u c o s y l  s p h i n g o s i n e .  
d I n c u b a t i o n  i n c l u d e d  10 m M  g l u c o n o l a c t o n e .  
above. After incubating the mixture for 2 hr 
with brain at pH 6 (phosphate), 7.2 and 8 (Tris), 
we lyophilized the suspension and measured the 
radioactivity in the collected water. (In the case 
of the samples containing Celite, the powder 
had to be removed before lyophilization to 
prevent flaking and carryover into the con- 
denser.) In no case was tri t ium found in the 
water, indicating a lack of a dehydrogenase that 
could attack the 6 position of the sugar. 
DISCUSSION 
Disregarding the obvious dangers of re- 
porting negative findings and of not trying 
every possible buffer and incubation medium, 
we conclude that neither glucosyl nor galac- 
tosyl ceramide is metabolized by young brain 
to form the corresponding hexosyl sphingosine. 
Our finding of hitherto undetected galacto- 
cerebroside derivatives of a polar type raises the 
possibility that these are toxic in the brain of 
the Krabbe child, and that their accumulation 
has not been noticed in previous examinations 
of the brain lipids. More likely, in our opinion, 
the seriousness of infantile Krabbe's and 
Gaucher's diseases is due to malfunction of a 
thus far unknown role of the cerebroside 
hydrolases. Preliminary evidence with a glucosi- 
dase inhibitor and cultured brain tumor cells 
suggests a role in membrane transport (19). 
The observations that hexosyl sphingosines 
can be formed enzymatically from the free base 
and UDP-Hexose (20,21) and that the hexosyl 
sphingosines can be hydrolyzed to free base and 
hexose are attributed to nonspecificity on the 
part of the cerebroside synthetases and hydro- 
lases. Support for this interpretation comes 
from the fact that the "unnatural"  reactions are 
somewhat slower than the "natural"  ones and 
the fact that the hydrolase activity toward 
galactosyl sphingosine is severely deficient in 
Krabbe's disease (5). 
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